These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30456352)

  • 81. Mycobacterium tuberculosis Rv1473 is a novel macrolides ABC Efflux Pump regulated by WhiB7.
    Duan W; Li X; Ge Y; Yu Z; Li P; Li J; Qin L; Xie J
    Future Microbiol; 2019 Jan; 14():47-59. PubMed ID: 30539658
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Identification of Compounds with pH-Dependent Bactericidal Activity against Mycobacterium tuberculosis.
    Early J; Ollinger J; Darby C; Alling T; Mullen S; Casey A; Gold B; Ochoada J; Wiernicki T; Masquelin T; Nathan C; Hipskind PA; Parish T
    ACS Infect Dis; 2019 Feb; 5(2):272-280. PubMed ID: 30501173
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The Host Microbiota Contributes to Early Protection Against Lung Colonization by
    Dumas A; Corral D; Colom A; Levillain F; Peixoto A; Hudrisier D; Poquet Y; Neyrolles O
    Front Immunol; 2018; 9():2656. PubMed ID: 30487801
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Neutrophils: Innate Effectors of TB Resistance?
    Kroon EE; Coussens AK; Kinnear C; Orlova M; Möller M; Seeger A; Wilkinson RJ; Hoal EG; Schurr E
    Front Immunol; 2018; 9():2637. PubMed ID: 30487797
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Toxin-antitoxin systems shows variability among Mycobacterium tuberculosis lineages.
    Solano-Gutierrez JS; Pino C; Robledo J
    FEMS Microbiol Lett; 2019 Jan; 366(1):. PubMed ID: 30476068
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c.
    Cloete R; Kapp E; Joubert J; Christoffels A; Malan SF
    PLoS One; 2018; 13(11):e0207605. PubMed ID: 30475855
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Mce-associated protein Rv0177 alters the cell wall structure of Mycobacterium smegmatis and promotes macrophage apoptosis via regulating the cytokines.
    Yan S; Zhen J; Li Y; Zhang C; Stojkoska A; Lambert N; Li Q; Li P; Xie J
    Int Immunopharmacol; 2019 Jan; 66():205-214. PubMed ID: 30472521
    [TBL] [Abstract][Full Text] [Related]  

  • 88.
    Yang J; Zhang L; Qiao W; Luo Y
    MedComm (2020); 2023 Oct; 4(5):e353. PubMed ID: 37674971
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Evaluating the Impact of the Tyr158 p
    Davoodi S; Daryaee F; Iuliano JN; Tolentino Collado J; He Y; Pollard AC; Gil AA; Aramini JM; Tonge PJ
    Biochemistry; 2023 Jun; 62(12):1943-1952. PubMed ID: 37270808
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development.
    Yan W; Zheng Y; Dou C; Zhang G; Arnaout T; Cheng W
    Mol Biomed; 2022 Dec; 3(1):48. PubMed ID: 36547804
    [TBL] [Abstract][Full Text] [Related]  

  • 91. How
    Bhagwat A; Deshpande A; Parish T
    Front Cell Infect Microbiol; 2022; 12():974101. PubMed ID: 36159638
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Boron Advantage: The Evolution and Diversification of Boron's Applications in Medicinal Chemistry.
    Messner K; Vuong B; Tranmer GK
    Pharmaceuticals (Basel); 2022 Feb; 15(3):. PubMed ID: 35337063
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Designing of a Chimeric Vaccine Using EIS (Rv2416c) Protein Against Mycobacterium tuberculosis H37Rv: an Immunoinformatics Approach.
    Logesh R; Lavanya V; Jamal S; Ahmed N
    Appl Biochem Biotechnol; 2022 Jan; 194(1):187-214. PubMed ID: 34817805
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A Novel Benzoxaborole Is Active against Escherichia coli and Binds to FabI.
    Mandal S; Parish T
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0262220. PubMed ID: 34152809
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Organoboron Compounds: Effective Antibacterial and Antiparasitic Agents.
    Coghi PS; Zhu Y; Xie H; Hosmane NS; Zhang Y
    Molecules; 2021 May; 26(11):. PubMed ID: 34072937
    [TBL] [Abstract][Full Text] [Related]  

  • 96. InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis.
    Flint L; Korkegian A; Parish T
    PLoS One; 2020; 15(11):e0239354. PubMed ID: 33201882
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Structural approaches to pathway-specific antimicrobial agents.
    Johnson ME; Fung LW
    Transl Res; 2020 Jun; 220():114-121. PubMed ID: 32105648
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model.
    Robertson GT; Ektnitphong VA; Scherman MS; McNeil MB; Dennison D; Korkegian A; Smith AJ; Halladay J; Carter DS; Xia Y; Zhou Y; Choi W; Berry PW; Mao W; Hernandez V; Alley MRK; Parish T; Lenaerts AJ
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745397
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Discovery of a cofactor-independent inhibitor of
    Xia Y; Zhou Y; Carter DS; McNeil MB; Choi W; Halladay J; Berry PW; Mao W; Hernandez V; O'Malley T; Korkegian A; Sunde B; Flint L; Woolhiser LK; Scherman MS; Gruppo V; Hastings C; Robertson GT; Ioerger TR; Sacchettini J; Tonge PJ; Lenaerts AJ; Parish T; Alley M
    Life Sci Alliance; 2018 Jun; 1(3):e201800025. PubMed ID: 30456352
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis.
    Inturi B; Pujar GV; Purohit MN
    Arch Pharm (Weinheim); 2016 Nov; 349(11):817-826. PubMed ID: 27775177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.